SG Americas Securities’s iShares US Pharmaceuticals ETF IHE Stock Holding History
Bought
Maintained
Sold
Other funds holding IHE
IWS
SG Americas Securities's IHE Position: Q2 2026 in Review
SG Americas Securities opened a new position in iShares US Pharmaceuticals ETF (IHE) in Q2 2026: 5,296 shares worth $524K. The stake represents ﹤0.01% of the portfolio and ranks #2301 among its holdings. This is a return to the name: SG Americas Securities previously reported a position in IHE as recently as Q2 2018.
SG Americas Securities first reported a position in IHE in Q3 2013 and has held it in 19 quarters since. The position peaked at $3.29M in Q1 2015. 210 funds tracked by Wall St. Rank hold IHE as of Q2 2026.
- SG Americas Securities held 5,296 shares of iShares US Pharmaceuticals ETF worth $524K as of Q2 2026.
- iShares US Pharmaceuticals ETF was a new SG Americas Securities position in Q2 2026.
- iShares US Pharmaceuticals ETF made up ﹤0.01% of SG Americas Securities's portfolio in Q2 2026, its #2301 holding.
- SG Americas Securities first reported a position in iShares US Pharmaceuticals ETF in Q3 2013 and has held it in 19 quarters since.
- SG Americas Securities's iShares US Pharmaceuticals ETF position peaked at $3.29M in Q1 2015.
- 210 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q2 2026.
Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.